Reshape Lifesciences (FRA:24O0) Days Sales Outstanding : 93.43 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Reshape Lifesciences Days Sales Outstanding?

Reshape Lifesciences's average Accounts Receivable for the three months ended in Jun. 2024 was €1.87 Mil. Reshape Lifesciences's Revenue for the three months ended in Jun. 2024 was €1.83 Mil. Hence, Reshape Lifesciences's Days Sales Outstanding for the three months ended in Jun. 2024 was 93.43.

The historical rank and industry rank for Reshape Lifesciences's Days Sales Outstanding or its related term are showing as below:

FRA:24O0' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.13 Med: 106.27 Max: 540.28
Current: 109.3

During the past 13 years, Reshape Lifesciences's highest Days Sales Outstanding was 540.28. The lowest was 38.13. And the median was 106.27.

FRA:24O0's Days Sales Outstanding is ranked worse than
81.83% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: 65.105 vs FRA:24O0: 109.30

Reshape Lifesciences's Days Sales Outstanding declined from Jun. 2023 (103.84) to Jun. 2024 (93.43).

Reshape Lifesciences Days Sales Outstanding Historical Data

The historical data trend for Reshape Lifesciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reshape Lifesciences Days Sales Outstanding Chart

Reshape Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

71.74

142.93

98.21

102.73

107.88

Reshape Lifesciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															103.84	116.54	127.58	105.16	93.43

Competitive Comparison of Reshape Lifesciences's Days Sales Outstanding

For the Medical Devices subindustry, Reshape Lifesciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reshape Lifesciences's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reshape Lifesciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Reshape Lifesciences's Days Sales Outstanding falls into.

Reshape Lifesciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Reshape Lifesciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2.445	+	2.259)	/	2 )	/	7.958	*	365
=	2.352					/	7.958	*	365
=	107.88

Reshape Lifesciences's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (1.862	+	1.875)	/	2 )	/	1.825	*	365 / 4
=	1.8685					/	1.825	*	365 / 4
=	93.43

Reshape Lifesciences (FRA:24O0) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Reshape Lifesciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Reshape Lifesciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Reshape Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reshape Lifesciences Inc (FRA:24O0) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RSLS:USA

Address

1001 Calle Amanecer, San Clemente, CA, USA, 92673

Website

https://www.reshapelifesciences.com

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Reshape Lifesciences Headlines

No Headlines